ECSP961663A - NON-INORGANIC SALINE SOLUTIONS FOR ENDONASAL ADMINISTRATION - Google Patents

NON-INORGANIC SALINE SOLUTIONS FOR ENDONASAL ADMINISTRATION

Info

Publication number
ECSP961663A
ECSP961663A ECSP961663A ECSP961663A EC SP961663 A ECSP961663 A EC SP961663A EC SP961663 A ECSP961663 A EC SP961663A EC SP961663 A ECSP961663 A EC SP961663A
Authority
EC
Ecuador
Prior art keywords
saline solutions
inorganic saline
endonasal administration
endonasal
administration
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Paolo Alberto Veronesi
Emanuela Peschechera
Anna Maria Veronesi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP961663 priority Critical patent/ECSP961663A/en
Publication of ECSP961663A publication Critical patent/ECSP961663A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Contienen:a) una calcitonina, preferentemente salmón, como acetato, caracterizada por contener además los excipientes orgánicos; b) N-(metilo)-glucamina (meglumina); c) trometamina; d) ácido cítrico y; e) polivinilpirrolidona del tipo incluído entre K15 y K20. Estas son sin olor y sabor y por lo tanto tienen una mejor aceptación por parte de los pacientes y no tienen los inconvenientes no deseables de las composiciones conocidas y además permiten un completo y cuidadoso análisis del principio activo y desarrollan menos productos de degradación en el curso de los períodos de almacenamiento.They contain: a) a calcitonin, preferably salmon, as acetate, characterized by also containing organic excipients; b) N- (methyl) -glucamine (meglumine); c) tromethamine; d) citric acid and; e) polyvinylpyrrolidone of the type included between K15 and K20. These are odorless and tasteless and therefore have a better acceptance by patients and do not have the undesirable drawbacks of the known compositions and also allow a thorough and careful analysis of the active ingredient and develop fewer degradation products in the course of storage periods.

ECSP961663 1996-02-05 1996-02-05 NON-INORGANIC SALINE SOLUTIONS FOR ENDONASAL ADMINISTRATION ECSP961663A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP961663 ECSP961663A (en) 1996-02-05 1996-02-05 NON-INORGANIC SALINE SOLUTIONS FOR ENDONASAL ADMINISTRATION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP961663 ECSP961663A (en) 1996-02-05 1996-02-05 NON-INORGANIC SALINE SOLUTIONS FOR ENDONASAL ADMINISTRATION

Publications (1)

Publication Number Publication Date
ECSP961663A true ECSP961663A (en) 1997-06-27

Family

ID=42042397

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP961663 ECSP961663A (en) 1996-02-05 1996-02-05 NON-INORGANIC SALINE SOLUTIONS FOR ENDONASAL ADMINISTRATION

Country Status (1)

Country Link
EC (1) ECSP961663A (en)

Similar Documents

Publication Publication Date Title
AR001458A1 (en) Pharmaceutical composition for transdermal administration.
ES2088312T3 (en) CONTROLLED RELEASE FORMULATION CONTAINING TRAMADOL.
AR040722A1 (en) FORMULATIONS AND DOSAGE FORMS FOR THE CONTROLLED ADMINISTRATION OF TOPIRAMATO
NO20062619L (en) Controlled release dosing system for nasal applications
ES2566395T3 (en) Pharmaceutical formulations / compositions of guanfacine suitable for single daily dose
MX9202961A (en) PHARMACEUTICAL FORMS OF TABLETS OR PELLETS SUITABLE FOR ORAL ADMINISTRATION, WHICH ARE STABLE DURING STORAGE AND CONTAIN PANTOPRAZOLE AS AN ACTIVE SUBSTANCE.
CA2477301A1 (en) Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of myelodysplastic syndromes
AR062647A1 (en) PHARMACEUTICAL FORMULATIONS AND METHODS OF USE
DE60024491D1 (en) FAST-ACTIVE, FREEZER-DRY, ORAL, PHARMACEUTICAL FORMULATION FOR TREATMENT OF MIGRAINE
CO5130023A1 (en) ADMINISTRATION OF ACTIVE AGENT IN DRY POWDER ACTIVE AGENT AND AN HYBROSCOPIC GROWTH INHIBITOR
CR7099A (en) ANTRANILAMIDS, PROCEDURE FOR THEIR PREPARATION, ITS USE AS ANTIARRITHMIC AND PHARMACEUTICAL PREPARATIONS OF THE SAME
UY27553A1 (en) PHARMACEUTICAL FORMULATIONS OF 5,7,14-TRIAZATETRACICLO (10.3.1.02,11.04,9) -HEXADECA-2/11), 3,5,7,9-PENTAENO
MX9200992A (en) PHARMACEUTICAL COMPOSITION THAT HAS AS ACTIVE INGREDIENT 3- [2- (DIMETHYLAMINE) ETHYL] -N-METHYL-1H-INDOL-5-METHANOSULFONAMIDE AND PROCEDURE FOR ITS PREPARATION.
CY1107966T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING METFORMINE AND GLIBENCLAMIDE FOR THE TREATMENT OF TYPE II DIABETES
CO5170471A1 (en) MODIFIED RELEASE TABLETS INCLUDING AMOXYLIN AND POTASSIUM CLAVULANATE
DE50005529D1 (en) ORAL PHARMACEUTICAL FORMS FOR ADMINISTRATING A FIXED COMBINATION OF TRAMADOL AND DICLOFENAC
ES2034926T1 (en) LIQUID ORAL PHARMACEUTICAL COMPOSITIONS WITH ANTI-INFLAMMATORY ACTIVITY.
AR024998A1 (en) NEW RETINOIDS FOR THE TREATMENT OF THE DISEASE
ES2054949T3 (en) DOPAMINE PRECURSORS.
ES2057225T3 (en) A COMPOSITION FOR THE PREPARATION OF AN ACTIVE VITAMIN D3 IN A DOSAGE FORM AND ITS PREPARATION PROCEDURE.
AR008820A1 (en) TABLET PROVIDED WITH TRIMEBUTINE MALEATE LAMINATE COATING, INTENDED FOR ADMINISTRATION BY ORAL USE, AND A PROCEDURE FOR PREPARING IT
ES2131863T3 (en) DERIVATIVES OF COLCHICINA AND ITS THERAPEUTIC USE.
ECSP961663A (en) NON-INORGANIC SALINE SOLUTIONS FOR ENDONASAL ADMINISTRATION
TR200200473T2 (en) Rar selective retinoid agonists.
ATE38151T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING STABLE 5-ADENOSYL-L-METHIONINE SALTS FOR ORAL USE.